|
|
||||||||
Na+-K+-2Cl- cotransport activity was measured in ferret erythrocytes as the bumetanide-sensitive uptake of 86Rb.
The Na+-K+-2Cl- cotransport rate was stimulated by treating erythrocytes with sodium arsenite but not by sodium arsenate (up to 1 mM). Stimulation took an hour to develop fully. Arsenite had no effect on bumetanide-resistant 86Rb uptake.
In cells stored for 3 days or less, cotransport stimulation by arsenite could be described by assuming arsenite either acts at a single site (EC50, 60 ± 14 µM, mean ± s.e.m., n = 3) or that it acts at both high- (EC50, 35 ± 9 µM, mean ± s.e.m., n = 3) and low- (EC50 > 2 mM) affinity sites.
Stimulation by 1 mM arsenite was greatest on the day of cell collection (rate about 3 times that of the control), even exceeding that produced by 20 nM calyculin A, and declined during cell storage. Addition of calyculin A to arsenite-stimulated cells resulted in further stimulation of Na+-K+-2Cl- cotransport, suggesting that arsenite and calyculin act synergistically. This was most apparent in stored cells.
Stimulation by 1 mM arsenite was not affected by treating cells with the mitogen-activated protein kinase inhibitors SB203580 (20 µM) and PD98059 (50 µM), but was both prevented and reversed by the kinase inhibitors staurosporine (2 µM), 4-amino-5-(4-methylphenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine (PP1, 50 µM) and genistein (0·3 mM), and with a combination of 10 µM A23187 and 2 mM EDTA (to reduce intracellular Mg2+ concentration). Only treatment with EDTA and A23187 prevented stimulation by the combination of 1 mM arsenite and 20 nM calyculin, whereas no treatment was able to fully reverse this stimulation once elicited.
Our data are consistent with arsenite stimulating (perhaps indirectly) a kinase that phosphorylates and activates the Na+-K+-2Cl- cotransporter.
This article has been cited by other articles:
![]() |
Y. Jing, J. A. Dowdy, M. R. Van Scott, and J. S. Fedan Hyperosmolarity-Induced Dilation and Epithelial Bioelectric Responses of Guinea Pig Trachea in Vitro: Role of Kinase Signaling J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 186 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B. E. Gagnon, R. England, and E. Delpire Characterization of SPAK and OSR1, Regulatory Kinases of the Na-K-2Cl Cotransporter Mol. Cell. Biol., January 15, 2006; 26(2): 689 - 698. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W Flatman Activation of ferret erythrocyte Na+-K+-2Cl- cotransport by deoxygenation J. Physiol., March 1, 2005; 563(2): 421 - 431. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhao, R. Hyde, and H. S Hundal Signalling mechanisms underlying the rapid and additive stimulation of NKCC activity by insulin and hypertonicity in rat L6 skeletal muscle cells J. Physiol., October 1, 2004; 560(1): 123 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Piechotta, N. Garbarini, R. England, and E. Delpire Characterization of the Interaction of the Stress Kinase SPAK with the Na+-K+-2Cl- Cotransporter in the Nervous System: EVIDENCE FOR A SCAFFOLDING ROLE OF THE KINASE J. Biol. Chem., December 26, 2003; 278(52): 52848 - 52856. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |